Cytoderm is committed to a demanding sustainability approach, balancing scientific effectiveness, social responsibility, and environmental respect. This charter guides all our decisions, from formulation to production and patient use.
Social commitment
Cytoderm is developed and manufactured within a structure employing around 90% people with disabilities. This inclusive model reflects a strong belief: performance must go hand in hand with human impact.
Natural formulation and high standards
Cytoderm is formulated exclusively with natural ingredients, carefully selected for both efficacy and safety. Boswellic acid, the key active ingredient, is known for its anti-inflammatory and soothing properties. This is reflected in a high Yuka rating between 93 and 100.
We are committed to excluding controversial substances and ensuring full transparency.
Responsible therapeutic alternative
Cytoderm offers an alternative to cortisone-based treatments, respecting both patient physiology and long-term health. Our goal is to deliver effective care without compromising safety.
Local production and reduced footprint
Cytoderm prioritizes local sourcing and Belgian production to minimize carbon footprint and support local economies.
Transparency and continuous improvement
Cytoderm is committed to clear communication and continuous improvement, guided by science and evolving societal expectations.